Veloxis is a specialty pharmaceutical company committed to improving the lives of transplant patients. Our unique, patented delivery technology, MeltDose®, is designed to enhance the absorption and bioavailability of select orally administered drugs.
Veloxis is an international company with headquarters in Hørsholm, Denmark, and a fully owned subsidiary in Edison, New Jersey, USA.
Veloxis is committed to patient access and financial support for kidney transplant patients. Learn more about our prescription cost savings programs, click here
|Q1 2016 Presentation
Conference call at 3:00 pm CEST
Please dial in 5-10 minutes prior to the start time using the number / Conference ID below.
UK: +44(0)20 3427 1910
US: +1 646 254 3362
DK: +45 32 71 16 59
Confirmation Code: 8446996